2280 - A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC After Neoadjuvant Chemoimmunotherapy

03:00pm - 04:00pm ET

Poster Hall - Exhibit Hall A

Presenter(s)

Hang Yin, MD, PhD - Harbin Medical University Cancer Hospital, Harbin, Heilongjia